The Journal of Parkinson's Disease (JPD) publishes original research in basic science, translational research and clinical medicine in Parkinson’s disease in cooperation with the Journal of Alzheimer's Disease. It features a first class Editorial Board and provides rigorous peer review and rapid online publication.
For subscription information, click here.
JPD's targeted audience is comprised of basic science researchers and clinicians in the areas of Parkinson’s disease and related disorders.
JPD has a Journal Impact Factor of 5.568, a 5-Year Impact Factor of 5.732, and a Journal Citation Indicator of 0.94 (2020 Journal Citation Reports, source: Clarivate, 2021).
Chemical Abstracts Service (CAS), Embase, Journal Citation Reports/Science Edition, MEDLINE, PsycINFO, PubsHub, Science Citation Index-Expanded (SciSearch®), Scopus
To receive news and JAD updates, sign up via this link: http://tiny.cc/JPDsignup
Find JPD on Facebook at: facebook.com/journalpd
Follow JPD on Twitter at: twitter.com/journal_pd
IOS Press serves the information needs of scientific and medical communities worldwide. IOS Press publishes more than 100 international journals and approximately 75 book titles each year
on subjects ranging from computer sciences and mathematics to medicine and natural sciences.
Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.
All journals are available in print and electronic format.